Global PARITY: Study Design for a Multi-Centered, International Point Prevalence Study to Estimate the Burden of Pediatric Acute Critical Illness in Resource-Limited Settings.
acute pediatric care
critical care
low resource setting
low-and lower-middle-income countries
outcome
pediatric critical illness
resource utilization
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2021
2021
Historique:
received:
12
10
2021
accepted:
10
12
2021
entrez:
14
2
2022
pubmed:
15
2
2022
medline:
15
2
2022
Statut:
epublish
Résumé
The burden of pediatric critical illness and resource utilization by children with critical illness in resource limited settings (RLS) are largely unknown. Without specific data that captures key aspects of critical illness, disease presentation, and resource utilization for pediatric populations in RLS, development of a contextual framework for appropriate, evidence-based interventions to guide allocation of limited but available resources is challenging. We present this methods paper which describes our efforts to determine the prevalence, etiology, hospital outcomes, and resource utilization associated with pediatric acute, critical illness in RLS globally. We will conduct a prospective, observational, multicenter, multinational point prevalence study in sixty-one participating RLS hospitals from North, Central and South America, Africa, Middle East and South Asia with four sampling time points over a 12-month period. Children aged 29 days to 14 years evaluated for acute illness or injury in an emergency department) or directly admitted to an inpatient unit will be enrolled and followed for hospital outcomes and resource utilization for the first seven days of hospitalization. The primary outcome will be prevalence of acute critical illness, which Global PARITY has defined as death within 48 hours of presentation to the hospital, including ED mortality; or admission/transfer to an HDU or ICU; or transfer to another institution for a higher level-of-care; or receiving critical care-level interventions (vasopressor infusion, invasive mechanical ventilation, non-invasive mechanical ventilation) regardless of location in the hospital, among children presenting to the hospital. Secondary outcomes include etiology of critical illness, in-hospital mortality, cause of death, resource utilization, length of hospital stay, and change in neurocognitive status. Data will be managed via REDCap, aggregated, and analyzed across sites. This study is expected to address the current gap in understanding of the burden, etiology, resource utilization and outcomes associated with pediatric acute and critical illness in RLS. These data are crucial to inform future research and clinical management decisions and to improve global pediatric hospital outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
The burden of pediatric critical illness and resource utilization by children with critical illness in resource limited settings (RLS) are largely unknown. Without specific data that captures key aspects of critical illness, disease presentation, and resource utilization for pediatric populations in RLS, development of a contextual framework for appropriate, evidence-based interventions to guide allocation of limited but available resources is challenging. We present this methods paper which describes our efforts to determine the prevalence, etiology, hospital outcomes, and resource utilization associated with pediatric acute, critical illness in RLS globally.
METHODS
METHODS
We will conduct a prospective, observational, multicenter, multinational point prevalence study in sixty-one participating RLS hospitals from North, Central and South America, Africa, Middle East and South Asia with four sampling time points over a 12-month period. Children aged 29 days to 14 years evaluated for acute illness or injury in an emergency department) or directly admitted to an inpatient unit will be enrolled and followed for hospital outcomes and resource utilization for the first seven days of hospitalization. The primary outcome will be prevalence of acute critical illness, which Global PARITY has defined as death within 48 hours of presentation to the hospital, including ED mortality; or admission/transfer to an HDU or ICU; or transfer to another institution for a higher level-of-care; or receiving critical care-level interventions (vasopressor infusion, invasive mechanical ventilation, non-invasive mechanical ventilation) regardless of location in the hospital, among children presenting to the hospital. Secondary outcomes include etiology of critical illness, in-hospital mortality, cause of death, resource utilization, length of hospital stay, and change in neurocognitive status. Data will be managed via REDCap, aggregated, and analyzed across sites.
DISCUSSION
CONCLUSIONS
This study is expected to address the current gap in understanding of the burden, etiology, resource utilization and outcomes associated with pediatric acute and critical illness in RLS. These data are crucial to inform future research and clinical management decisions and to improve global pediatric hospital outcomes.
Identifiants
pubmed: 35155314
doi: 10.3389/fped.2021.793326
pmc: PMC8835113
doi:
Types de publication
Journal Article
Langues
eng
Pagination
793326Subventions
Organisme : NIAID NIH HHS
ID : K23 AI144029
Pays : United States
Informations de copyright
Copyright © 2022 Abbas, Holloway, Caporal, López-Barón, Agulnik, Remy, Appiah, Attebery, Fink, Lee, Hooli, Kissoon, Miller, Murthy, Muttalib, Nielsen, Puerto-Torres, Rodrigues, Sakaan, Rodrigues, Tabor, von Saint Andre-von Arnim, Wiens, Blackwelder, He, Kortz and Bhutta.
Déclaration de conflit d'intérêts
DH is the owner of Analytical Solutions Group, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Intensive Care. 2015 Oct 09;3:40
pubmed: 26457187
N Engl J Med. 2011 Jun 30;364(26):2483-95
pubmed: 21615299
Front Pediatr. 2017 Dec 22;5:277
pubmed: 29312909
Am J Respir Crit Care Med. 2015 May 15;191(10):1147-57
pubmed: 25734408
Lancet. 2013 Apr 20;381(9875):1417-1429
pubmed: 23582723
PLoS Med. 2010 Dec 14;7(12):e1000379
pubmed: 21179496
Pediatr Crit Care Med. 2017 Apr;18(4):330-342
pubmed: 28207570
JAMA Pediatr. 2017 Jun 1;171(6):573-592
pubmed: 28384795
Lancet Respir Med. 2019 Feb;7(2):115-128
pubmed: 30361119
Paediatr Anaesth. 2009 Jan;19(1):23-7
pubmed: 19076498
Cancer. 2021 May 15;127(10):1668-1678
pubmed: 33524166
Inj Prev. 2020 Oct;26(Supp 1):i96-i114
pubmed: 32332142
Crit Care Med. 2021 Apr 1;49(4):671-681
pubmed: 33337665
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
World J Crit Care Med. 2016 May 04;5(2):150-64
pubmed: 27152258
J Perinatol. 2005 Jan;25(1):47-53
pubmed: 15372062
Lancet. 2016 Oct 8;388(10053):1725-1774
pubmed: 27733285
Pediatr Crit Care Med. 2010 Nov;11(6):681-9
pubmed: 20228688